Students at centers like BioTC in OKC and other locations are training to step into jobs that didn’t even exist a decade ago ...

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

Using patented purification methods and a community-first growth strategy, the Root Brands is redefining what it means to ...

Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...

As of Monday, December 08, Legend Biotech Corporation’s LEGN share price has dipped by 8.82%, which has investors questioning if this is right time to buy.

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

The Department of Health and Human Services recently canceled $500 million in funding for vaccine research that it had previously pledged to scientists.

The US Congress is poised to enact bipartisan legislation that would block some Chinese biotechnology companies from ...

The SBIO ETF has staged a remarkable comeback, outperforming despite a challenging macro backdrop and small-cap weakness.

Biotechnology can be used in the packaging of beauty products and has a significant sustainability impact that is good for ...

In other news, ASH is upon us! If you’re going to be in Orlando, don’t forget to drop by STAT’s event tomorrow evening.